SRZN
SurrozenBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
SRZN vs peer average
76/100
SRZN vs. peer average (B vs. D)
Grade spread
A 1 · B 1 · C 3 · D 1 · F 4
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
PRLD is the first available peer comparator.
Small-cap development-stage biotech with valuation sensitivity to pipeline milestones and capital access; helps frame how early-stage program timing can move equity value.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
SRZN
Surrozen
PRLD
Prelude Therapeutics
Grade
B
A
Momentum
38
85
Value
41
41
Sentiment
91
75
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs PRLD
SRZN / PRLD
Grade Position
Above peers
SRZN vs. peer average (B vs. D)
76/100
Momentum
38
PRLDValue
41
SRZNSentiment
91
SRZNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs SRZN
PRLD is the first peer returned for this comparison set.